Quantitative proteomic analysis of ibuprofen-degrading Patulibacter sp. strain I11

Biodegradation

Volumn 24, Issue 5, 2013, Pages 615-630

  Almeida, B ^a,b   Kjeldal, H ^d   Lolas, I ^d   Knudsen, A D ^d   Carvalho, G ^a,c   Nielsen, K L ^d   Barreto Crespo, M T ^a,b   Stensballe, A ^d   Nielsen, J L ^d  

^a IBET   (Portugal)

^b INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

^c DEPARTAMENTO DE QUÍMICA   (Portugal)

^d AALBORG UNIVERSITY   (Denmark)

Author keywords

Aromatic compounds; Degradation; Ibuprofen; Patulibacter sp.; Quantitative proteomics

Indexed keywords

BACTERIAL PROTEOMES; BIOLOGICAL PROCESS; IBUPROFEN; PATULIBACTER SP; PHARMACEUTICAL DRUGS; PROTEIN IDENTIFICATION; QUANTITATIVE PROTEOMIC ANALYSIS; QUANTITATIVE PROTEOMICS;

AROMATIC COMPOUNDS; DEGRADATION; MOLECULAR BIOLOGY;

PROTEINS;

BIODEGRADATION; DRUG; PROTEIN; PROTEOMICS; QUANTITATIVE ANALYSIS;

BACTERIA (MICROORGANISMS); PATULIBACTER;

BACTERIAL PROTEIN; IBUPROFEN; MESSENGER RNA; PROTEOME;

ACTINOBACTERIA; ARTICLE; BIOREMEDIATION; DOWN REGULATION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; GENOMICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; METHODOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEOMICS; UPREGULATION;

ACTINOBACTERIA; BACTERIAL PROTEINS; BIODEGRADATION, ENVIRONMENTAL; DOWN-REGULATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENE EXPRESSION REGULATION, BACTERIAL; GENOMICS; IBUPROFEN; PROTEOME; PROTEOMICS; RNA, MESSENGER; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 84880946541     PISSN: 09239820     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10532-012-9610-5     Document Type: Article

References (57)

1. Aziz RK, Bartels D, Best AA, DeJongh M, Disz T, Edwards RA, Formsma K, Gerdes S, Glass EM, Kubal M, Meyer F, Olsen GJ, Olson R, Osterman AL, Overbeek RA, McNeil LK, Paarmann D, Paczian T, Parrello B, Pusch GD, Reich C, Stevens R, Vassieva O, Vonstein V, Wilke A, Zagnitko O (2008) The RAST server: rapid annotations using subsystems technology. BMC Genomics 9: 75.
2. Bhatia VN, Perlman DH, Costello CE, McComb ME (2009) Software tool for researching annotations of proteins: open-source protein annotation software with data visualization. Anal Chem 81: 9819-9823.
3. Buser HR, Poiger T, Muller MD (1999) Occurrence and environmental behavior of the chiral pharmaceutical drug ibuprofen in surface waters and in wastewater. Environ Sci Technol 33: 2529-2535.
4. Cao B, Loh K-C (2009) Physiological comparison of Pseudomonas putida between two growth phases during cometabolism of 4-chlorophenol in presence of phenol and glutamate: a proteomics approach. J Chem Technol Biotechnol 84: 1178-1185.
5. Chen YJ, Rosazza JPN (1994) Microbial transformation of ibuprofen by a Nocardia Species. Appl Environ Microbiol 60: 1292-1296.
6. Craven SH, Ezezika OC, Haddad S, Hall RA, Momany C, Neidle EL (2009) Inducer responses of BenM, a LysR-type transcriptional regulator from Acinetobacter baylyi ADP1. Mol Microbiol 72: 881-894.
7. Daughton CG, Ternes TA (1999) Pharmaceuticals and personal care products in the environment: agents of subtle change? Environ Health Perspect 107: 907-938.
8. Ferrandez A, Minambres B, Garcia B, Olivera ER, Luengo JM, Garcia JL, Diaz E (1998) Catabolism of phenylacetic acid in Escherichia coli: characterization of a new aerobic hybrid pathway. J Biol Chem 273: 25974-25986.
9. Gibson DT, Parales RE (2000) Aromatic hydrocarbon dioxygenases in environmental biotechnology. Curr Opin Biotechnol 11: 236-243.
10. Giuffrida MG, Pessione E, Mazzoli R, Dellavalle G, Barello C, Conti A, Giunta C (2001) Media containing aromatic compounds induce peculiar proteins in Acinetobacter radioresistens, as revealed by proteome analysis. Electrophoresis 22: 1705-1711.
11. Haussmann U, Qi S-W, Wolters D, Roegner M, Liu S-J, Poetsch A (2009) Physiological adaptation of Corynebacterium glutamicum to benzoate as alternative carbon source-a membrane proteome-centric view. Proteomics 9: 3635-3651.
12. Heberer T (2002) Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol Lett 131: 5-17.
13. Hegde PS, White IR, Debouck C (2003) Interplay of transcriptomics and proteomics. Curr Opini Biotechnol 14: 647-651.
14. Jensen LJ, Skovgaard M, Brunak S (2002) Prediction of novel archaeal enzymes from sequence-derived features. Protein Sci 11: 2894-2898.
15. Kagle J, Porter AW, Murdoch RW, Rivera-Cancel G, Hay AG (2009) Biodegradation of pharmaceutical and personal care products. Adv Appl Mircobiol 67: 65-108.
16. Kim SJ, Jones RC, Cha CJ, Kweon O, Edmondson RD, Cerniglia CE (2004) Identification of proteins induced by polycyclic aromatic hydrocarbon in Mycobacterium vanbaalenii PYR-1 using two-dimensional polyacrylamide gel electrophoresis and de novo sequencing methods. Proteomics 4: 3899-3908.
17. Kim SI, Choi JS, Kahng HY (2007) A proteomics strategy for the analysis of bacterial biodegradation pathways. OMICS 11: 280-294.
18. Kim SJ, Kweon O, Cerniglia CE (2009) Proteomic applications to elucidate bacterial aromatic hydrocarbon metabolic pathways. Curr Opin Microbiol 12: 301-309.
19. Kolpin DW, Furlong ET, Meyer MT, Thurman EM, Zaugg SD, Barber LB, Buxton HT (2002) Pharmaceuticals, hormones, and other organic wastewater contaminants in US streams, 1999-2000: a national reconnaissance. Environ Sci Technol 36: 1202-1211.
20. Kummerer K (2009) The presence of pharmaceuticals in the environment due to human use -present knowledge and future challenges. J Environ Manage 90: 2354-2366.
21. Lagesen K, Hallin P, Rodland EA, Staerfeldt H-H, Rognes T, Ussery DW (2007) RNAmmer: consistent and rapid annotation of ribosomal RNA genes. Nucleic Acids Res 35: 3100-3108.
22. Liang Y, Gardner DR, Miller CD, Chen D, Anderson AJ, Weimer BC, Sims RC (2006) Study of biochemical pathways and enzymes involved in pyrene degradation by Mycobacterium sp. strain KMS. Appl Environ Microbiol 72: 7821-7828.
23. Liu W, Saint DA (2002) A new quantitative method of real time reverse transcription polymerase chain reaction assay based on simulation of polymerase chain reaction kinetics. Anal Biochem 302: 52-59.
24. Loh K-C, Cao B (2008) Paradigm in biodegradation using Pseudomonas putida-a review of proteomics studies. Enzyme Microb Technol 43: 1-12.
25. Luengo JM, Arias S, Olivera R (2007) The catabolism of phenylacetic acid and other related molecules in Pseudomonas putida U. In: Filloux A, Ramos J-L (eds) Pseudomonas, vol 2. Springer, New York, pp 147-192.
26. Martinez-Blanco H, Reglero A, Rodriguez-Aparicio LB, Luengo JM (1990) Purification and biochemical characterization of phenylacetyl-CoA ligase from Pseudomonas putida-a specific enzyme for the catabolism of phenylacetic acid. J Biol Chem 265: 7084-7090.
27. Murdoch RW, Hay AG (2005) Formation of catechols via removal of acid side chains from ibuprofen and related aromatic acids. Appl Environ Microbiol 71: 6121-6125.
28. Murray KE, Thomas SM, Bodour AA (2010) Prioritizing research for trace pollutants and emerging contaminants in the freshwater environment. Environ Pollut 158: 3462-3471.
29. Nadeau LJ, He Z, Spain JC (2003) Bacterial conversion of hydroxylamino aromatic compounds by both lyase and mutase enzymes involves intramolecular transfer of hydroxyl groups. Appl Environ Microbiol 69: 2786-2793.
30. Navarro-Llorens JM, Patrauchan MA, Stewart GR, Davies JE, Eltis LD, Mohn WW (2005) Phenylacetate catabolism in Rhodococcus sp strain RHA1: a central pathway for degradation of aromatic compounds. J Bacteriol 187: 4497-4504.
31. Oehmen A, Fradinho J, Serra S, Carvalho G, Capelo JL, Velizarov S, Crespo JG, Reis MA (2009) The effect of carbon source on the biological reduction of ionic mercury. J Hazard Mater 165: 1040-1048.
32. Onesios KM, Yu JT, Bouwer EJ (2009) Biodegradation and removal of pharmaceuticals and personal care products in treatment systems: a review. Biodegradation 20: 441-466.
33. Pal A, Gin KY, Lin AY, Reinhard M (2010) Impacts of emerging organic contaminants on freshwater resources: review of recent occurrences, sources, fate and effects. Sci Total Environ 408: 6062-6069.
34. Park S-H, Kim J-W, Yun S-H, Leem SH, Kahng H-Y, Kim SI (2006) Characterization of beta-ketoadipate pathway from multi-drug resistance bacterium, Acinetobacter baumannii DU202 by proteomic approach. J Microbiol 44: 632-640.
35. Patrauchan MA, Florizone C, Dosanjh M, Molm WW, Davies J, Eltis LD (2005) Catabolism of benzoate and phthalate in Rhodococcus sp strain RHA1: redundancies and convergence. J Bacteriol 187: 4050-4063.
36. Pérez-Pantoja D, González B, Pieper DH (2009) Aerobic degradation of aromatic hydrocarbons. In: Timmis KN (ed) Handbook of hydrocarbon and lipid microbiology. Springer, New York, pp 799-837.
37. Pessione E, Giuffrida MG, Prunotto L, Barello C, Mazzoli R, Fortunato D, Conti A, Giunta C (2003) Membrane proteome of Acinetobacter radioresistens S13 during aromatic exposure. Proteomics 3: 1070-1076.
38. Quintana JB, Weiss S, Reemtsma T (2005) Pathways and metabolites of microbial degradation of selected acidic pharmaceutical and their occurrence in municipal wastewater treated by a membrane bioreactor. Water Res 39: 2654-2664.
39. Roma-Rodrigues C, Santos PM, Benndorf D, Rapp E, Sa-Correia I (2010) Response of Pseudomonas putida KT2440 to phenol at the level of membrane proteome. J Proteomics 73: 1461-1478.
40. Salgado R, Noronha JP, Oehmen A, Carvalho G, Reis MA (2010) Analysis of 65 pharmaceuticals and personal care products in 5 wastewater treatment plants in Portugal using a simplified analytical methodology. Water Sci Technol 62: 2862-2871.
41. Salgado R, Marques R, Noronha JP, Mexia JT, Carvalho G, Oehmen A, Reis MA (2011) Assessing the diurnal variability of pharmaceutical and personal care products in a full-scale activated sludge plant. Environ Poll 159: 2359-2367.
42. Salgado R, Marques R, Noronha JP, Carvalho G, Oehmen A, Reis MA (2012) Assessing the removal of pharmaceuticals and personal care products in a full-scale activated sludge plant. Environ Sci Poll Res Int 19: 1818-1827.
43. Santos LH, Araujo AN, Fachini A, Pena A, Delerue-Matos C, Montenegro MCBSM (2010) Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment. J Hazard Mater 175: 45-95.
44. Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3: 1101-1108.
45. Shevchenko A, Tomas H, Havlis J, Olsen JV, Mann M (2006) In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc 1: 2856-2860.
46. Simpson JT, Wong K, Jackman SD, Schein JE, Jones SJ, Birol I (2009) ABySS: a parallel assembler for short read sequence data. Genome Res 19: 1117-1123.
47. Sommer DD, Delcher AL, Salzberg SL, Pop M (2007) Minimus: a fast, lightweight genome assembler. BMC Bioinformatics 8: 64.
48. Talaat AM, Howard ST, Hale W IV, Lyons R, Garner H, Johnston SA (2002) Genomic DNA standards for gene expression profiling in Mycobacterium tuberculosis. Nucleic Acids Res 30: e104.
49. Taylor CF, Binz PA, Aebersold R, Affolter M, Barkovich R, Deutsch EW, Horn DM, Hühmer A, Kussmann M, Lilley K, Macht M, Mann M, Müller D, Neubert TA, Nickson J, Patterson SD, Raso R, Resing K, Seymour SL, Tsugita A, Xenarios I, Zeng R, Julian RK Jr (2008) Guidelines for reporting the use of mass spectrometry in proteomics. Nat Biotechnol 26: 860-861.
50. Tomas-Gallardo L, Canosa I, Santero E, Camafeita E, Calvo E, Lopez JA, Floriano B (2006) Proteomic and transcriptional characterization of aromatic degradation pathways in Rhodoccocus sp. strain TFB. Proteomics 6: 119-132.
51. VerBerkmoes N, Denef V, Hettich R, Banfield J (2009) Functional analysis of natural microbial consortia using community proteomics. Nat Rev Microbiol 7: 196-205.
52. Winkler M, Lawrence JR, Neu TR (2001) Selective degradation of ibuprofen and clofibric acid in two model river biofilm systems. Water Res 35: 3197-3205.
53. Ying G-G, Kookana RS, Kolpin DW (2009) Occurrence and removal of pharmaceutically active compounds in sewage treatment plants with different technologies. J Environ Monit 11: 1498-1505.
54. Yun S-H, Park GW, Kim JY, Kwon SO, Choi C-W, Leem S-H, Kwon K-H, Yoo JS, Lee C, Kim S, Kim SI (2011) Proteomic characterization of the Pseudomonas putida KT2440 global response to a monocyclic aromatic compound by iTRAQ analysis and 1DE-MudPIT. J Proteomics 74: 620-628.
55. Zhang L, Fan F, Palmer LM, Lonetto MA, Petit C, Voelker LL, St John A, Bankosky B, Rosenberg M, McDevitt D (2000) Regulated gene expression in Staphylococcus aureus for identifying conditional lethal phenotypes and antibiotic mode of action. Gene 255: 297-305.
56. Zwiener C, Frimmel FH (2003) Short-term tests with a pilot sewage plant and biofilm reactors for the biological degradation of the pharmaceutical compounds clofibric acid, ibuprofen, and diclofenac. Sci Total Environ 309: 201-211.
57. Zwiener C, Seeger S, Glauner T, Frimmel FH (2002) Metabolites from the biodegradation of pharmaceutical residues of ibuprofen in biofilm reactors and batch experiments. Anal Bioanal Chem 372: 569-575.